|
1
|
Brewer Gutierrez OI and Lennon AM:
Pancreatic Cysts: Sinister Findings or Incidentalomas? Med Clin
North Am. 103:163–172. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dorobanţu BM, Matei E, Herlea V, Boroş M,
Tivadar B and Ciurea SH: Diagnosis, morphopathological profile and
treatment of mucinous cystadenoma of the pancreas - a single center
experience. Rom J Morphol Embryol. 59:1155–1163. 2018.PubMed/NCBI
|
|
3
|
Becker WF, Welsh RA and Pratt HS:
Cystadenoma and cystadenocarcinoma of the pancreas. Ann Surg.
161:845–863. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katoh H, Rossi RL, Braasch JW, Munson JL,
Shimozawa E and Tanabe T: Cystadenoma and cystadenocarcinoma of the
pancreas. Hepatogastroenterology. 36:424–430. 1989.PubMed/NCBI
|
|
5
|
Doulamis IP, Mylonas KS, Kalfountzos CE,
Mou D, Haj-Ibrahim H and Nasioudis D: Pancreatic mucinous
cystadenocarcinoma: Epidemiology and outcomes. Int J Surg.
35:76–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lichtenstein L:
Papillarycystadenocarcinoma of pancreas. case report, with notes on
classification of malignant cystic tumors of pancreas. Am J Cancer.
21:542–553. 1934. View Article : Google Scholar
|
|
7
|
Le Borgne J, de Calan L and Partensky C;
French Surgical Association, : Cystadenomas and cystadenocarcinomas
of the pancreas: A multiinstitutional retrospective study of 398
cases. Ann Surg. 230:152–161. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Compagno J and Oertel JE: Mucinous cystic
neoplasms of the pancreas with overt and latent malignancy
(cystadenocarcinoma and cystadenoma). A clinicopathologic study of
41 cases. Am J Clin Pathol. 69:573–580. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Roosbroeck K and Calin GA: Cancer
Hallmarks and MicroRNAs: The Therapeutic Connection. Adv Cancer
Res. 135:119–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rawat M, Kadian K, Gupta Y, Kumar A, Chain
PSG, Kovbasnjuk O, Kumar S and Parasher G: MicroRNA in Pancreatic
Cancer: From Biology to Therapeutic Potential. Genes (Basel).
10:752–773. 2019. View Article : Google Scholar
|
|
12
|
Zhang B, Guo X, Zhang J, Liu X, Zhan X and
Li Z: MicroRNA 224 is downregulated in mucinous cystic neoplasms of
the pancreas and may regulate tumorigenesis by targeting Jagged1.
Mol Med Rep. 10:3303–3309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aaltonen LA and Hamilton SR: World Health
Organization, International Agency for Research on Cancer.
Pathology and Genetics of Tumours of the Digestive System. Oxford
University Press; Lyon, Oxford: 2000
|
|
14
|
Li S, Zhang J, Zhao Y, Wang F, Chen Y and
Fei X: miR-224 enhances invasion and metastasis by targeting HOXD10
in non-small cell lung cancer cells. Oncol Lett. 15:7069–7075.
2018.PubMed/NCBI
|
|
15
|
Zhou J, Hu M, Wang F, Song M, Huang Q and
Ge B: miR-224 Controls Human Colorectal Cancer Cell Line HCT116
Proliferation by Targeting Smad4. Int J Med Sci. 14:937–942. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu Y, Huang W, Chen H, Wei H, Luo A, Xia
G, Deng X and Zhang G: MicroRNA-224, negatively regulated by c-jun,
inhibits growth and epithelial-to-mesenchymal transition phenotype
via targeting ADAM17 in oral squamous cell carcinoma. J Cell Mol
Med. 23:4913–4920. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cullen PK Jr, Remine WH and Dahlin DC: A
clinicopathological study of cystadenocarcinoma of the pancreas.
Surg Gynecol Obstet. 117:189–195. 1963.PubMed/NCBI
|
|
18
|
Chang R, Song L, Xu Y, Wu Y, Dai C, Wang
X, Sun X, Hou Y, Li W, Zhan X, et al: Loss of Wwox drives
metastasis in triple-negative breast cancer by JAK2/STAT3 axis. Nat
Commun. 9:34862018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song L, Guo J, Chang R, Peng X, Li J, Xu
X, Zhan X and Zhan L: LKB1 obliterates Snail stability and inhibits
pancreatic cancer metastasis in response to metformin treatment.
Cancer Sci. 109:1382–1392. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Chang R, Ji W, Wang N, Qi M, Xu Y,
Guo J and Zhan L: Loss of Scribble Promotes Snail Translation
through Translocation of HuR and Enhances Cancer Drug Resistance. J
Biol Chem. 291:291–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hieronymus H, Iaquinta PJ, Wongvipat J,
Gopalan A, Murali R, Mao N, Carver BS and Sawyers CL: Deletion of
3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in
prostate oncogenesis. Nat Commun. 8:1081–1090. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang C, Wang Z, Zhang K, Dong Y, Zhang A,
Lu C and Liu L: MicroRNA-107 inhibits proliferation and invasion of
laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in
vitro. Anticancer Drugs. 31:260–271. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma X, Feng J, Lu M, Tang W, Han J, Luo X,
Zhao Q and Yang L and Yang L: microRNA-501-5p promotes cell
proliferation and migration in gastric cancer by downregulating
LPAR1. J Cell Biochem. 121:1911–1922. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye J, Xie W, Zuo Y, Jing G and Tong J:
MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF
in osteosarcoma. Exp Ther Med. 19:1425–1431. 2020.PubMed/NCBI
|
|
27
|
Guo C, Peng X, Song L, Ying M, Wu Y, Chang
R, Li J, Feng D, Zhan L and Zhan X: Autophagy promotes malignant
migration and invasion via miR-224-5p/BCL2 in pancreatic mucinous
cystadenocarcinoma MCC1 cells. Oncol Lett. 20:2762020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Li P, Li B, Sun P, Zhang J, Wang B
and Jia B: RKIP suppresses gastric cancer cell proliferation and
invasion and enhances apoptosis regulated by microRNA-224. Tumour
Biol. 35:10095–10103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie
F, Lei L, Chen Y, Mao B, Jiang M, et al: miR-224 promotion of cell
migration and invasion by targeting Homeobox D 10 gene in human
hepatocellular carcinoma. J Gastroenterol Hepatol. 29:835–842.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin ZY, Huang YQ, Zhang YQ, Han ZD, He HC,
Ling XH, Fu X, Dai QS, Cai C, Chen JH, et al: MicroRNA-224 inhibits
progression of human prostate cancer by downregulating TRIB1. Int J
Cancer. 135:541–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brown JA and Bourke E: Practical
Bioinformatics Analysis of miRNA Data Using Online Tools. Methods
Mol Biol. 1509:195–208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB and Burge CB: Prediction of mammalian
microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M,
et al: Combinatorial microRNA target predictions. Nat Genet.
37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu B and Wei Y: Antitumor activity of
celastrol by inhibition of proliferation, invasion, and migration
in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Cancer Med.
9:783–796. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ramírez-Moya J, Wert-Lamas L and
Santisteban P: MicroRNA-146b promotes PI3K/AKT pathway
hyperactivation and thyroid cancer progression by targeting PTEN.
Oncogene. 37:3369–3383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin Y, Chen Q, Liu QX, Zhou D, Lu X, Deng
XF, Yang H, Zheng H and Qiu Y: High expression of DJ-1 promotes
growth and invasion via the PTEN-AKT pathway and predicts a poor
prognosis in colorectal cancer. Cancer Med. 7:809–819. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao YS, Yang WC, Xin HW, Han JX and Ma
SG: miR-182-5p knockdown targeting PTEN inhibits cell proliferation
and invasion of breast cancer cells. Yonsei Med J. 60:148–157.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang XM, Yu XN, Liu TT, Zhu HR, Shi X,
Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Huang XX, et al:
microRNA-19a-3p promotes tumor metastasis and chemoresistance
through the PTEN/Akt pathway in hepatocellular carcinoma. Biomed
Pharmacother. 105:1147–1154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Macgregor-Das AM and Iacobuzio-Donahue CA:
Molecular pathways in pancreatic carcinogenesis. J Surg Oncol.
107:8–14. 2013. View Article : Google Scholar : PubMed/NCBI
|
